Last quarter (Q2 2023), Mydecine Innovations Group's total revenue was C$―, a decrease of ― from the same quarter last year. In Q2, Mydecine Innovations Group's net income was C$-3.18M. See Mydecine Innovations Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	C$ 7.49K	C$ 2.62K	C$ 125.57K	C$ 207.66K
Cost of Revenue	-	-	-	-	C$ 94.05K	C$ 109.82K
Gross Profit	-	-	C$ 7.49K	C$ 2.62K	C$ 31.52K	C$ 97.83K
Operating Expense	C$ 15.24M	C$ 16.39M	C$ 22.69M	C$ 11.46M	C$ 3.43M	C$ 5.90M
Operating Income	C$ -15.24M	C$ -16.39M	C$ -22.68M	C$ -11.46M	C$ -3.39M	C$ -5.81M
Net Non Operating Interest Income Expense	C$ -678.95K	C$ -664.07K	C$ 205.27K	C$ 182.87K	C$ 80.52K	C$ 63.11K
Other Income Expense	C$ 3.88M	C$ 12.69K	C$ -693.51K	C$ -15.23M	C$ -17.95M	C$ -7.49M
Pretax Income	C$ -19.99M	C$ -17.24M	C$ -23.58M	C$ -26.88M	C$ -21.43M	C$ -13.36M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	C$ 333.60K	-	-
Net Income Common Stockholders	C$ -14.31M	C$ -11.57M	C$ -28.90M	C$ -26.95M	C$ -21.43M	C$ -13.36M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 15.24M	C$ 16.39M	C$ -22.69M	C$ -11.46M	C$ -3.52M	C$ -6.01M
Net Income From Continuing And Discontinued Operation	C$ -14.31M	C$ -11.57M	C$ -28.90M	C$ -26.95M	C$ -21.43M	C$ -13.36M
Normalized Income	C$ -14.38M	C$ -12.36M	C$ -17.33M	C$ -3.65M	C$ 2.36M	C$ -1.99M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -19.06M	C$ -16.33M	C$ -23.38M	C$ -26.69M	C$ -21.35M	C$ -13.29M
EBITDA	C$ -19.02M	C$ -16.20M	C$ -23.14M	C$ -26.64M	C$ -21.30M	C$ -13.26M

Currency in CAD

Mydecine Innovations Group Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing